在患有帕金森病的人群中进行群体平衡运动:通过元分析进行系统性审查
Rebecca A States1, Birendra Dewan2, Peggy Lynam2
1Doctor of Physical Therapy Program, Hofstra University, Hempstead, NY, USA.
Physiotherapy theory and practice
|July 8, 2024
概括
在帕金森病患者中,团体炼可能比不炼更能改善平衡. 无论是团体运动还是个人运动,都会产生类似的平衡效益,鼓励基于偏好和可访问性的参与.
科学领域:
- 神经学 神经学
- 物理疗法物理治疗
- 康复医学 康复医学 康复医学
背景情况:
- 高质量的证据支持运动可以改善帕金森病 (PD) 患者的功能能力,包括平衡.
- 炼设置 (集团与个人) 对 PD 余额结果的影响仍未得到充分研究.
- 本系统性审查将群体炼与个人炼进行比较,并对PD患者进行非炼对照组.
研究的目的:
- 在帕金森病中系统地审查和元分析团体运动对不运动对照对平衡的影响.
- 为了比较群体运动与个人运动在帕金森病中平衡的有效性.
- 为PD中平衡改善提供基于证据的运动方式建议.
主要方法:
- 在MEDLINE,EMBASE,CINAHL和Cochrane CENTRAL数据库中进行了系统的文献搜索,截至2024年3月24日.
- 包括的研究是随机对照试验 (RCT),调查帕金森病患者平衡的运动干预措施.
- 进行了元分析,以比较使用临床平衡措施的群体炼与对照和个人炼.
主要成果:
- 包括27个RCT (30份报告),涉及1200名参与者.
- 与对照组相比,运动小组在定时上升和去测试,Mini-BESTest和Berg平衡量级上显示出显著的改善.
- 在比较群体炼与个人炼时,没有发现平衡结果的显著差异.
结论:
- 与没有运动的对照组相比,在帕金森病中的特定平衡措施中,团体炼可能会带来更高的益处.
- 对于患有帕金森病的人来说,团体和个人炼干预似乎对平衡产生了可比的效果.
- 鼓励帕金森病患者定期进行团体或个人炼,优先考虑个人偏好和可访问性.
相关概念视频
Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522


